Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia
Objective: To investigate patient perspectives on the therapeutic effects of botulinum toxin type-A (BoNT-A) in cervical dystonia (CD) using patient s on-line survey. Background: CD…Restoration of Ambulation in an Adolescent with Tardive Dystonia after Pallidal DBS
Objective: To describe clinical and local field potential changes in an adolescent with tardive dystonia after bilateral globus pallidus interna (GPi) DBS. Background: Tardive dystonia…Huntington’s Disease Care and Patient Diversity in California, United States
Objective: Describe HD patient demographics and healthcare utilization based on Huntington’s Disease Society of America (HDSA) Center of Excellence (COE) status using the California (CA)…Response Inhibition and Cortical Excitability in selected SCA subtypes in an Indian Cohort
Objective: This study examined response inhibition deficits using the Stop-Signal Reaction Time (SSRT) paradigm in different Spinocerebellar Ataxia (SCA) subtypes and explored cortical involvement through…A retrospective analysis of an FMD IDC: considerations that impact outcomes.
Objective: We aimed to evaluate the impact of demographics, clinical characteristics, and comorbidities on treatment follow up and outcomes in patients from an interdisciplinary FMD…Neurodegenerative Langerhans Cell Histiocytosis: A Rare Cause of Cerebellar Ataxia
Objective: To describe a rare case of progressive cerebellar ataxia due to neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) and highlight diagnostic challenges with atypical imaging findings.…Physical, Mental, and Socioemotional Functional Improvement Following Valbenazine Treatment for TD: a Case Series
Objective: Describe clinical characteristics and changes in mental, socioemotional, and physical domains of individuals with tardive dyskinesia (TD) after valbenazine (VBZ) treatment. Background: Prior research…Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies
Objective: Analyze the nutritional status, motor and non-motor symptoms of patients with Parkinson´s disease (PD) with second-line therapies [levodopa carbidopa intestinal gel (LCIG) and deep…PARKinSOUND 2.0: The Impact of Orchestra Participation on Patients with Parkinson’s Disease
Objective: This study evaluates the impact of participation in a community orchestra on people with PD. Background: As interest in non-pharmacological therapies for Parkinson’s disease…Parkinson’s Progression Markers Initiative (PPMI): A Biomarker Engine for Therapeutic Development for PD and Related Synucleinopathies
Objective: PPMI is a longitudinal, observational study investigating clinical, imaging, genetic and biofluid biomarkers to accelerate therapeutic development for Parkinson’s disease (PD) and related synucleinopathies…
- « Previous Page
- 1
- …
- 172
- 173
- 174
- 175
- 176
- …
- 181
- Next Page »